780 results on '"Bernatsky, S."'
Search Results
2. POS0168 ROTAVIRUS VACCINE IN OFFSPRING EXPOSED TO TUMOUR NECROSIS FACTOR INHIBITORS DOES NOT INCREASE DIARRHEA-ASSOCIATED HEALTHCARE EVENTS: REAL-WORLD EVIDENCE TO GUIDE BEST PRACTICES
3. POS0898 PREGNANT WOMEN ON TNFI MAY HAVE HIGHER RISK OF HOSPITALIZATION FOR INFECTIONS DURING GESTATION AND POSTPARTUM
4. A252 DRUG DISCONTINUATION AND PERSISTENT SYMPTOMS AMONG THE USERS OF BIOSIMILAR AND LEGACY ANTI-TNF DRUGS IN A REAL-WORLD CANADIAN IBD COHORT
5. Tumour necrosis factor inhibitors and serious infections in reproductive-age women and their offspring: a narrative review
6. P672 Occurrence of malignancy among infliximab biosimilar and bio-originator initiators in Canada: a comparative population-based analysis
7. Cardiovascular events prior to or early after diagnosis of systemic lupus erythematosus in the systemic lupus international collaborating clinics cohort
8. N-terminal pro-brain natriuretic peptide (NT-proBNP) et dommage cardiovasculaire chez les patients suivis pour un lupus systémique : une étude transversale
9. Challenges to optimal rheumatology care: a patient-centered focus group study
10. Anti-C1q antibodies in systemic lupus erythematosus
11. Factors associated with waiting times for persons with rheumatic conditions in multidisciplinary pain treatment facilities
12. Cancer risk in childhood-onset systemic lupus
13. Breast Cancer in Systemic Lupus Erythematosus
14. AB1294 SAFETY OF COVID-19 VACCINES AND HEALTH CARE UTILIZATION FOLLOWING VACCINATION AMONG ADULTS WITH RHEUMATOID ARTHRITIS – A POPULATION-BASED SELF-CONTROLLED CASE SERIES ANALYSIS
15. POS0936 TUMOUR NECROSIS FACTOR INHIBITORS USE AND DISCONTINUATION AMONG PREGNANT WOMEN WITH CHRONIC INFLAMMATORY DISEASES
16. POS1151 THERAPEUTIC DRUG MONITORING OF AZATHIOPRINE AND TACROLIMUS IN SLE PREGNANCIES: PRELIMINARY RESULTS FROM THE LEGACY COHORT
17. AB0409 TIME TO FIRST REMISSION AND PREVALENCE OF SUSTAINED REMISSION AFTER ETANERCEPT BIOSIMILAR (ETA-B) OR ORIGINATOR (ETA-O) INITIATION IN RHEUMATOID ARTHRITIS (RA)
18. A170 ADVERSE EVENTS & SEROLOGICAL RESPONSES FOLLOWING SARS-COV-2 VACCINATION IN INDIVIDUALS WITH INFLAMMATORY BOWEL DISEASE
19. Machine learning identifies clusters of longitudinal autoantibody profiles predictive of systemic lupus erythematosus disease outcomes.
20. S15.2 Severe non-adherence to hydroxychloroquine is associated with flares, early damage, and mortality in systemic lupus erythematosus: data from 660 patients from the slicc inception cohort
21. Impact of the COVID-19 pandemic on maternal mental health during pregnancy: The CONCEPTION study – Phase I
22. AB1089 PSYCHOSOCIAL IMPACTS OF THE COVID-19 PANDEMIC ON ETHIOPIAN AND CANADIAN RHEUMATOLOGY PATIENTS
23. OP0130 SERIOUS INFECTIONS IN OFFSPRING EXPOSED TO TUMOUR NECROSIS FACTOR INHIBITORS DURING PREGNANCY: COMPARISON OF AGENTS WITH LOW AND HIGH PLACENTAL TRANSFER
24. P247 Comparison of discontinuation/switching between infliximab biosimilar and originator among Inflammatory Bowel Disease patients: a real-world analysis of two Canadian cohorts
25. Antidepressant use and 10-year incident fracture risk: the population-based Canadian Multicentre Osteoporosis Study (CaMoS)
26. Biologic disease-modifying anti-rheumatic drugs and the risk of non-vertebral osteoporotic fractures in patients with rheumatoid arthritis aged 50 years and over
27. OP0286 CHARACTERISTICS ASSOCIATED WITH SEVERE COVID-19 OUTCOMES IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): RESULTS FROM THE COVID-19 GLOBAL RHEUMATOLOGY ALLIANCE (COVID-19 GRA)
28. OP0018 PREDICTING RESPONSES TO ANTI-TNF TREATMENTS IN RHEUMATOID ARTHRITIS PATIENTS FROM GENETIC AND CLINICAL DATA USING A MACHINE LEARNING APPROACH
29. POS1420 RISK OF SERIOUS INFECTIONS IN OFFSPRING EXPOSED IN UTERO TO USTEKINUMAB OR VEDOLIZUMAB
30. OP0285 COVID-19 HOSPITALIZATIONS, ICU ADMISSION, AND DEATH AMONG PATIENTS WITH IMMUNE MEDIATED INFLAMMATORY DISEASES (IMID) – A POPULATION-BASED STUDY
31. OP0289 LLDAS (LOW LUPUS DISEASE ACTIVITY STATE), LOW DISEASE ACTIVITY (LDA) AND REMISSION (ON- OR OFF-TREATMENT) PREVENT DAMAGE ACCRUAL IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) PATIENTS IN A MULTINATIONAL MULTICENTER COHORT
32. POS0058-PARE INCREASING PREECLAMPSIA KNOWLEDGE IN SLE WITH A SPECIFIC EDUCATIONAL TOOL: PRELIMINARY RESULTS
33. POS0050 ARE PATIENTS WITH IMMUNE MEDIATED INFLAMMATORY DISEASES (IMID) MORE LIKELY TO RECEIVE COVID-19 TESTS AND TEST POSITIVE FOR SARS-COV-2? A MATCHED POPULATION-BASED STUDY
34. POS1268 COVID-19 VACCINE HESITANCY AMONG RHEUMATOLOGY PATIENTS RECEIVING INFLUENZA VACCINE
35. Surveillance of systemic autoimmune rheumatic diseases using administrative data
36. Application of a nomogram for exercise capacity in women with systemic lupus erythematosus
37. Lung cancer in systemic lupus erythematosus
38. Something’s missing here: a look at the quality of rheumatology referral letters
39. Prostate cancer in systemic lupus erythematosus
40. Autoantibodies as biomarkers for the prediction of neuropsychiatric events in systemic lupus erythematosus
41. SF-36 summary and subscale scores are reliable outcomes of neuropsychiatric events in systemic lupus erythematosus
42. The influence of systemic glucocorticoid therapy upon the risk of non-serious infection in older patients with rheumatoid arthritis: a nested case–control study
43. FRI0064 SAFETY OF LOW DOSE METHOTREXATE (MTX) AND TUBERCULOSIS (TB)
44. THU0154 PERCEPTIONS ABOUT INTERVENTIONS TO ENHANCE INFLUENZA VACCINE UPTAKE DIFFER BETWEEN VACCINATED AND UNVACCINATED RA/JIA PATIENTS
45. THU0179 PERSISTENCE IN RHEUMATOID ARTHRITIS PATIENTS ON BIOSIMILAR AND BIO-ORIGINATOR ETANERCEPT: A POOLED ANALYSIS OF PAN-CANADIAN COHORTS
46. SAT0078 SAFETY OF LOW DOSE METHOTREXATE (MTX) IN HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION
47. Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus
48. Rapidity of rheumatology consultation for people in an early inflammatory arthritis cohort
49. Polymyalgia Rheumatica Prevalence in a Population-Based Sample
50. Estimating the prevalence of polymyositis and dermatomyositis from administrative data: age, sex and regional differences
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.